Regorafinib escalation for colorectal cancer - RECC Study

Department of Coloproctological Surgery, Juntendo University Hospital0 个研究点目标入组 55 人开始时间: 2017年10月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)contraindications for Regorafinib 2)previously received chemotherapy with Regorafinib 3)severe drug allergy 4)pregnant woman or Possibility of the pregnant woman. male patient who hoping partner's pregnancy. 5)patient who has severe clinical complications (symptomatic unstable ischemic heart disease, arrhythmia, acute myocardial infarction within 6 months, liver cirrhosis, renal failure, active gastrointestinal ulcer, ileus, uncontrolled diabetes, uncontrolled hypertension, etc.) 6)other active malignancies 7)severe disorder of liver function 8)Uncontrollable hypertension 9)Severe complication 10)Synchronous or metachronous multiple malignancy within the last 5 year disease free interval 11)Under continuous steroid administration 12)decision of unsuitable for this study by the investigator

发起方

Department of Coloproctological Surgery, Juntendo University Hospital